FI66357C - Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiderivat av 2-isopropylaminopyrimidin - Google Patents

Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiderivat av 2-isopropylaminopyrimidin Download PDF

Info

Publication number
FI66357C
FI66357C FI800566A FI800566A FI66357C FI 66357 C FI66357 C FI 66357C FI 800566 A FI800566 A FI 800566A FI 800566 A FI800566 A FI 800566A FI 66357 C FI66357 C FI 66357C
Authority
FI
Finland
Prior art keywords
isopropylaminopyrimide
hydroxiders
framework
hydroxy
pharmacological properties
Prior art date
Application number
FI800566A
Other languages
English (en)
Finnish (fi)
Other versions
FI800566A (fi
FI66357B (fi
Inventor
Andre Esanu
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI66357(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of FI800566A publication Critical patent/FI800566A/fi
Application granted granted Critical
Publication of FI66357B publication Critical patent/FI66357B/fi
Publication of FI66357C publication Critical patent/FI66357C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI800566A 1979-03-10 1980-02-26 Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiderivat av 2-isopropylaminopyrimidin FI66357C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7908494 1979-03-10
GB7914987 1979-04-30
GB7914987 1979-04-30

Publications (3)

Publication Number Publication Date
FI800566A FI800566A (fi) 1980-09-11
FI66357B FI66357B (fi) 1984-06-29
FI66357C true FI66357C (fi) 1984-10-10

Family

ID=26270867

Family Applications (1)

Application Number Title Priority Date Filing Date
FI800566A FI66357C (fi) 1979-03-10 1980-02-26 Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiderivat av 2-isopropylaminopyrimidin

Country Status (24)

Country Link
JP (1) JPS55122768A (ja)
AR (1) AR222691A1 (ja)
AU (1) AU533547B2 (ja)
BE (1) BE881752A (ja)
CA (1) CA1132561A (ja)
CH (1) CH644368A5 (ja)
DE (3) DE3009071C2 (ja)
EG (1) EG14282A (ja)
FI (1) FI66357C (ja)
FR (2) FR2451191A1 (ja)
GB (1) GB2045756B (ja)
HK (1) HK55383A (ja)
IE (1) IE49547B1 (ja)
IN (1) IN153791B (ja)
LU (1) LU82185A1 (ja)
MX (1) MX6218E (ja)
MY (1) MY8400200A (ja)
NL (1) NL184833C (ja)
NO (1) NO154054C (ja)
NZ (1) NZ192927A (ja)
OA (1) OA06484A (ja)
PT (1) PT70882A (ja)
SE (1) SE435180B (ja)
SG (1) SG22683G (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Also Published As

Publication number Publication date
IE49547B1 (en) 1985-10-30
HK55383A (en) 1983-11-25
FI800566A (fi) 1980-09-11
GB2045756B (en) 1983-01-26
DE3009071A1 (de) 1980-09-11
EG14282A (en) 1983-09-30
NZ192927A (en) 1981-07-13
JPS55122768A (en) 1980-09-20
SE435180B (sv) 1984-09-10
DE3050999C2 (de) 1986-08-14
PT70882A (en) 1980-03-01
LU82185A1 (fr) 1980-06-06
DE3016752A1 (de) 1980-12-04
NL184468B (nl) 1989-03-01
IN153791B (ja) 1984-08-18
FR2451191A1 (fr) 1980-10-10
NO154054C (no) 1986-07-09
OA06484A (fr) 1981-07-31
SE8001812L (sv) 1980-09-11
NL184833C (nl) 1989-11-16
DE3050999A1 (ja) 1985-08-14
FR2451191B1 (ja) 1983-04-29
DE3009071C2 (de) 1985-11-14
SG22683G (en) 1983-12-16
NO800664L (no) 1980-09-11
FI66357B (fi) 1984-06-29
GB2045756A (en) 1980-11-05
FR2451370B1 (ja) 1983-05-13
CH644368A5 (en) 1984-07-31
MX6218E (es) 1984-12-21
FR2451370A1 (fr) 1980-10-10
NL184833B (nl) 1989-06-16
AU533547B2 (en) 1983-12-01
JPS6126996B2 (ja) 1986-06-23
AR222691A1 (es) 1981-06-15
AU5624880A (en) 1980-09-18
CA1132561A (en) 1982-09-28
DE3016752C2 (ja) 1987-06-25
IE800477L (en) 1980-09-10
NO154054B (no) 1986-04-01
NL8001289A (nl) 1980-09-12
MY8400200A (en) 1984-12-31
BE881752A (fr) 1980-05-30

Similar Documents

Publication Publication Date Title
FI66357C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiderivat av 2-isopropylaminopyrimidin
EP0316704B1 (de) Fluorcytidinderivate, deren Herstellung und Arzneimittel, die diese Derivate enthalten
FI71556B (fi) Foerfarande foer framstaellning av 5-(paradeuterofenyl)-5-fenylhydantoin vilken aer ett laekemedel anvaendbart mot konvulsioner
DE69715010T2 (de) Ausgewählte k-252a derivate
FI66615C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-alkoxiadeninderivat
FI66359C (fi) Foerfarande foer framstaellning av terapeutiskt verksamma hydroxiderivat av 2-isopropylamino-pyrimidin
FI56966C (fi) Foerfarande foer framstaellning av 2-(2-pyridyl)-omega-fenylalkylaminer med antisekretorisk aktivitet
DE2128375A1 (de) Neue basische (Substituiert-alkyliden)amino-oxyalkylcarbonsäureester
EP0228314A2 (en) Use of ethanol/amine derivatives in treating or preventing hyperlipemia
FI68045C (fi) Foerfarande foer framstaellning av terapeutiskt verkande 2-isopropylamino-5-fluor-pyrimidin
KR840001708B1 (ko) 하이드록시 피리미딘 유도체의 제조방법
US4464379A (en) Indol acetic acid derivatives and anti-inflamatory and related uses thereof
SU1001855A3 (ru) Способ получени 2-замещенных-1н-фенантро[9,10- @ ]имидазолов или их солей
EP0937089A1 (de) Neue knoevenagel-kondensationsprodukte, verfahren zu deren herstellung und verwendung
WO1992019597A1 (en) Gallic acid derivative, and pharmaceutical compositions containing it
DE3034005C2 (de) Indolessigsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
FI61687C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara ala-metyl-3,4-dihydroxifenylalaninderivat
FI63564C (fi) Foerfarande foer framstaellning av terapeutiskt aktiv n-2,6-diklorfenyl-2-aminopyrimidin
CN109206389A (zh) 异土木香内酯衍生物，其药物组合物及其用途
US4187311A (en) 3-Aryloxy-1-carboalkoxyethylpyridinium compounds and compositions
US3646010A (en) Spiroazetidine-ethanoanthracenes
DE2605824A1 (de) N-acylaniline, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JP2860385B2 (ja) ビスべンジルイソキノリン誘導体
KR101072698B1 (ko) 신규 메트로니다졸 전구체 화합물 및 이를 유효성분으로 함유하는 약학조성물
US4148993A (en) Process to produce 1-methyl isoguanosine

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SOCIETE D'ETUDES DE PRODUITS CHIMIQUES